[Prasugrel or ticagrelor in patients with acute coronary syndrome : Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 5 (ISAR-REACT 5)]
Internist (Berl)
.
2020 Feb;61(2):223-225.
doi: 10.1007/s00108-020-00752-w.
[Article in German]
Authors
A Schäfer
1
,
S Nitschmann
2
Affiliations
1
Klinik für Kardiologie und Angiologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30659, Hannover, Deutschland.
[email protected]
.
2
, Lippetal, Deutschland.
PMID:
32016492
DOI:
10.1007/s00108-020-00752-w
No abstract available
Publication types
Review
Comment
MeSH terms
Acute Coronary Syndrome*
Fibrinolytic Agents
Humans
Platelet Aggregation Inhibitors
Prasugrel Hydrochloride
Ticagrelor
Substances
Fibrinolytic Agents
Platelet Aggregation Inhibitors
Prasugrel Hydrochloride
Ticagrelor